Biotech ETFs Poised for Gains after Moderna Vaccine News
November 16, 2020 at 12:52 PM EST
Biotech ETFs are getting a boost along with stocks on Monday thanks to Moderna, which announced that its initial phase three trial data reveals a coronavirus vaccine that is over 94% effective. Shares of the Moderna surged over 12% in premarket trading, and are still up over 7.5%. Meanwhile,...